✦ LIBER ✦

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma

✍ Scribed by Kim, H. R.; Lim, S. M.; Kim, H. J.; Hwang, S. K.; Park, J. K.; Shin, E.; Bae, M. K.; Ou, S.- H. I.; Wang, J.; Jewell, S. S.; Kang, D. R.; Soo, R. A.; Haack, H.; Kim, J. H.; Shim, H. S.; Cho, B. C.

Book ID: 121721577
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 241 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and prognostic implications of

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

✍ Kim, Min Hwan; Shim, Hyo Sup; Kang, Dae Ryong; Jung, Ji Ye; Lee, Chang Young; Ki 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1007 KB

Conserved recurrent gene mutations corre

Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers

✍ Zhifu Sun,Liang Wang,Bruce W Eckloff,Bo Deng,Yi Wang… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 674 KB

Deep sequencing of the microRNA transcri

Deep sequencing of the microRNA transcriptome in current, former, and never smokers with lung adenocarcinoma

✍ Teresa W Wang, Josh D Campbell, Lingqi Luo, Gang Liu, Ji Xiao… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 81 KB

Distinct clinical features and outcomes

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement

✍ Hye Ryun Kim; Hyo Sup Shim; Jin-Haeng Chung; Young Joo Lee; Yun Kyoung Hong; Sun 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

## Abstract ## BACKGROUND: The objectives of this study were to determine the proportions of major oncogenic alterations and to examine survival in genotype‐specific subsets of never‐smokers with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors concurrently analyzed mutations in the ep

Impact of EGFR tyrosine kinase inhibitor

Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung

✍ Youngjoo Lee, Ji-Youn Han, Heung Tae Kim, Tak Yun… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 403 KB

Frequency of Driver Mutations in Lung Ad

Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis

✍ Zhang, Y.; Sun, Y.; Pan, Y.; Li, C.; Shen, L.; Li, Y.; Luo, X.; Ye, T.; Wang, R. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 456 KB